Antitrust & Competition Life Sciences Year in Review 2023 | Goodwin
Despite increasingly aggressive rhetoric from the agencies, 2022 was largely characterized as “business as usual” in the antitrust world. In contrast, 2023 featured a significant step...
Source: jdsupra.com